Please login to the form below

Not currently logged in
Email:
Password:

Roche engaged in talks with FDA for Alzheimer’s drug candidate

Alzweb1CEO Severin Schwan told reporters Roche will complete a phase 3 trial of gantenerumab in the second half of 2022

One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants

AZ NEWNew real-world data from Canada shows vaccine efficacy was lower against milder symptomatic disease with one dose

J&J, distributors reach $26bn settlement to address the opioid crisis in the US

J&J cottonwood driveThe proposed agreement would resolve claims of both states and local governments in the US

Novartis sees demand returning to pre-COVID-19 levels in Q2 results

Novartis buildingSwiss pharma company also provided key updates on a number of drug candidates in its pipeline

Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer

Merck & Co HQKeytruda plus Lenvima was previously approved under the FDA’s accelerated approval process

EU approves bluebird bio’s CALD gene therapy Skysona

Bluebird BioCALD is a progressive and fatal neurodegenerative disease that overwhelmingly affects males

NHS earmarks £340m for new medicines fund to fast-track ‘innovative’ treatments

NHS England logoThe proposed Innovative Medicines Fund is an extension of the existing Cancer Drugs Fund

EMA begins rolling review of Sanofi, GSK’s COVID-19 vaccine

Eu flag 2020 newRolling review launched based on preliminary results from lab studies and early clinical studies

Claire GillisQ&A: Claire Gillis

PME interviews VMLY&Rx's CEO

Latest appointments

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....